Protective effects of sinomenine against doxorubicin-induced nephrosis in rats

Journal of Asian Natural Products Research

Volumn 14, Issue 7, 2012, Pages 678-687

  Zhang, Jie ^a   Hu, Rong ^b   Xia, Zheng Kun ^a   Ren, Xian Guo ^a   Zhang, Li Wen ^c   Liang, Ya Hao ^c   Liu, Guang Ling ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

doxorubicin nephrosis; nephrin; podocyte injury; PPAR ; sinomenine

Indexed keywords

ALPHA ACTININ 4; DOXORUBICIN; INTERLEUKIN 1BETA; NEPHRIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PODOCIN; SINOMENINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CHEMICAL PARAMETERS; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ELECTRON MICROSCOPY; GLOMERULUS; IMMUNOHISTOCHEMISTRY; MALE; NEPHROTIC SYNDROME; NONHUMAN; PODOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; ULTRASTRUCTURE; URINALYSIS; WESTERN BLOTTING;

ANIMALS; DOXORUBICIN; INTERLEUKIN-1BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; MORPHINANS; NEPHROSIS; PPAR ALPHA; RATS; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS; SINOMENIUM ACUTUM;

EID: 84864718426     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2012.685070     Document Type: Article

References (23)

1. Eddy, A.A., and, Symons, J.M. 2003. Lancet, 362: 629
2. Nakhoul, F., Ramadan, R., and, Khankin, E. 2005. Am. J. Physiol.-Renal., 289: F880
3. Dai, C., Saleem, M.A., and, Holzman, L.B. 2010. Kidney Int., 77: 962
4. Zheng, C.X., Chen, Z.H., and, Zeng, C.H. 2008. Kidney Int., 74: 596
5. Liu, L., Buchner, E., and, Beitze, D. 1996. Int. J. Immunopharmacol., 18: 529
6. Cheng, Y., Zhang, J., and, Hou, W. 2009. Int. Immunopharmacol., 9: 894
7. Zhou, H., Wong, Y.F., and, Wang, J. 2008. Biochem. Biophys. Res. Commun., 376: 352
8. Wang, Q., and, Li, X.K. 2011. Int. Immunopharmacol., 11: 373
9. Guan, N., Ding, J., and, Deng, J. 2004. J. Pathol. Int., 54: 703
10. Kawachi, H., Miyauchi, N., and, Suzuki, K. 2006. Nephrology, 11: 274
11. Chen, Y., Li, J., and, Zhang, J. 2005. Int. Immunopharmacol., 5: 1446
12. He, X., Wang, J., and, Guo, Z. 2005. Immunol. Lett., 98: 91
13. Vieregge, B., Rausch, K., and, Kaever, V. 1999. Planta Med., 65: 80
14. Koop, K., Eikmans, M., and, Baelde, H.J. 2003. J. Am. Soc. Nephrol., 14: 2063
15. Zhang, S., Marlier, A., and, Gribouval, O. 2004. Kidney Int., 66: 945
16. Kestil, M., Lenkkeri, U., and, Mnnikk, M. 1998. Mol. Cell, 1: 575
17. Fan, Q., Xing, Y., and, Ding, J. 2006. Kidney Int., 69: 1207
18. Zhou, Y., Kong, X., and, Zhao, P. 2011. Kidney Int., 79: 1302
19. Benigni, A., Zoja, C., and, Tomasoni, S. 2006. J. Am. Soc. Nephrol., 17: 1624
20. Guan, Y., Zhang, Y., and, Davis, L. 1997. Am. J. Physiol.-Renal., 273: F1013
21. Nagothu, K.K., Bhatt, R., and, Kaushal, G.P. 2005. Kidney Int., 68: 2680
22. Lin, H., Hou, C.C., and, Cheng, C.F. 2007. Mol. Pharmacol., 72: 1238
23. Mori, K., Mukoyama, M., and, Nakao, K. 2011. Kidney Int., 79: 1274